Yahoo Web Search

Search results

1. • FY2025 EPS Estimates for AbbVie Inc. (NYSE:ABBV) Lowered by Analyst

     ETF DAILY NEWS· 5 days ago

     AbbVie Inc. (NYSE:ABBV – Free Report) – Investment analysts at William Blair dropped their FY2025 EPS estimates for shares of AbbVie in a report released on Wednesday, April 17th. William Blair ...

2. • AbbVie Inc. (NYSE:ABBV) to Post Q1 2024 Earnings of $2.21 Per Share, William Blair Forecasts

     ETF DAILY NEWS· 5 days ago

     AbbVie Inc. (NYSE:ABBV – Free Report) – Research analysts at William Blair issued their Q1 2024 EPS estimates for AbbVie in a research note issued to investors on Wednesday, April 17th. William ...

3. • Amgen Inc. (NASDAQ:AMGN) Short Interest Update

     ETF DAILY NEWS· 7 days ago

     Amgen Inc. (NASDAQ:AMGN – Get Free Report) saw a significant decline in short interest in the month of March. As of March 31st, there was short interest totalling 10,470,000 shares, a decline ...

4. • SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Ventyx...

     Morningstar· 5 days ago

     Pomerantz LLP announces that a class action lawsuit has been filed against Ventyx Biosciences, Inc. ("Ventyx" or the "Company") (NASDAQ: VTYX) and certain officers. The class action, filed in ...

5. • Sigma Planning Corp Has $1.85 Million Stock Holdings in Amgen Inc. (NASDAQ:AMGN)

     ETF DAILY NEWS· 3 days ago

     Sigma Planning Corp decreased its stake in Amgen Inc. (NASDAQ:AMGN – Free Report) by 65.9% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and ...

6. • CapWealth Advisors LLC Cuts Stake in Johnson & Johnson (NYSE:JNJ)

     ETF DAILY NEWS· 23 hours ago

     CapWealth Advisors LLC lowered its holdings in shares of Johnson & Johnson (NYSE:JNJ – Free Report) by 0.3% in the 4th quarter, according to its most recent Form 13F filing with the Securities ...

7. • UCB SA (OTCMKTS:UCBJY) Declares Dividend of $0.46

     ETF DAILY NEWS· 4 days ago

     UCB SA (OTCMKTS:UCBJY – Get Free Report) declared a dividend on Friday, April 19th, investing.com reports. Stockholders of record on Monday, April 29th will be given a dividend of 0.4574 per ...

8. • Cambridge Trust Co. Sells 1,280 Shares of Johnson & Johnson (NYSE:JNJ)

     ETF DAILY NEWS· 23 hours ago

     Cambridge Trust Co. reduced its stake in shares of Johnson & Johnson (NYSE:JNJ – Free Report) by 0.5% in the fourth quarter, according to its most recent filing with the SEC. The fund owned ...

9. • VTYX DEADLINE: ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Ventyx Biosciences, Inc. Investors to...

     Morningstar· 1 day ago

     NEW YORK, April 23, 2024 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Ventyx Biosciences, Inc. (NASDAQ: VTYX): (i) pursuant ...

10. • Sandoz confirms European Commission approval of Pyzchiva® (ustekinumab), further strengthening...

      Morningstar· 3 days ago

      Ad hoc announcement pursuant to art. 53 SIX Swiss Exchange Listing Rules Pyzchiva® approved as one of first ustekinumab biosimilars in EuropeEC approval based on robust development program confirming match to reference medicine in terms of safety